Jade Brown, MBA, is a seasoned professional in business development and licensing transactions within the life sciences sector. Serving as Principal at Jade Brown Life Sciences Transactional Advisor since June 2008, Jade Brown has a proven track record in areas such as immuno-oncology, autoimmune diseases, and infectious diseases, focusing on out-licensing and technology collaborations. Additionally, Jade Brown holds multiple roles as Transactional Advisor for several companies, including Sound Biologics, Amberstone Biosciences, Psilera, Aptevo Therapeutics Inc., Seal Rock Therapeutics, Inhalon Biopharma, StradBio, Cellectar Biosciences, and Externa Biosciences. An alumnus of Harvard Business School, Jade Brown graduated with an MBA and also holds a BS in Business with honors from Indiana University - Kelley School of Business.
This person is not in any teams
This person is not in any offices